Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Chinese (SSE) Healthcare Sector Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies472
  • 7D3.2%
  • 3M-3.4%
  • 1Y14.2%
  • YTD22.2%

Sichuan Biokin PharmaceuticalLtd is up 6.2%, leading the way for the Healthcare industry, which has gained 3.2%. In the same time, Wuhan Healthgen Biotechnology was down 9.4%. This takes the industry's 12 month performance to a gain of 14%. Earnings are forecast to grow by 25% annually.

Sector Valuation and Performance

Has the Chinese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Nov 2025CN¥6.8tCN¥2.3tCN¥145.1b41.8x47.1x3x
Wed, 15 Oct 2025CN¥6.6tCN¥2.3tCN¥146.9b38.8x44.9x2.9x
Fri, 12 Sep 2025CN¥7.0tCN¥2.2tCN¥142.2b41.3x49.1x3.2x
Sun, 10 Aug 2025CN¥6.7tCN¥2.2tCN¥152.8b39.8x43.8x3x
Tue, 08 Jul 2025CN¥6.0tCN¥2.2tCN¥150.0b36.1x40.2x2.7x
Thu, 05 Jun 2025CN¥6.1tCN¥2.2tCN¥150.1b36.5x40.6x2.8x
Sat, 03 May 2025CN¥5.6tCN¥2.3tCN¥194.5b32.5x28.8x2.4x
Mon, 31 Mar 2025CN¥5.8tCN¥2.2tCN¥157.2b32.7x36.6x2.6x
Wed, 26 Feb 2025CN¥5.7tCN¥2.2tCN¥153.7b32.1x36.9x2.5x
Fri, 24 Jan 2025CN¥5.3tCN¥2.2tCN¥153.7b30.7x34.8x2.4x
Sun, 22 Dec 2024CN¥5.8tCN¥2.2tCN¥153.7b33.8x37.7x2.6x
Tue, 19 Nov 2024CN¥5.8tCN¥2.2tCN¥154.1b33.2x37.5x2.6x
Thu, 17 Oct 2024CN¥5.6tCN¥2.2tCN¥161.8b31.4x34.4x2.5x
Sat, 14 Sep 2024CN¥4.8tCN¥2.2tCN¥161.9b27.1x29.4x2.1x
Mon, 12 Aug 2024CN¥5.1tCN¥2.3tCN¥166.2b28.1x30.9x2.3x
Wed, 10 Jul 2024CN¥5.0tCN¥2.3tCN¥167.0b27.6x30x2.2x
Fri, 07 Jun 2024CN¥5.5tCN¥2.3tCN¥164.9b29.2x33.5x2.4x
Sun, 05 May 2024CN¥5.9tCN¥2.3tCN¥167.8b32.3x35.3x2.6x
Tue, 02 Apr 2024CN¥5.9tCN¥2.3tCN¥172.9b30.8x33.9x2.6x
Thu, 29 Feb 2024CN¥5.8tCN¥2.3tCN¥178.9b28.6x32.2x2.5x
Sat, 27 Jan 2024CN¥5.8tCN¥2.3tCN¥176.9b30.2x32.9x2.5x
Mon, 25 Dec 2023CN¥6.3tCN¥2.3tCN¥177.1b33.7x35.8x2.8x
Wed, 22 Nov 2023CN¥6.7tCN¥2.3tCN¥177.2b36x37.8x2.9x
Fri, 20 Oct 2023CN¥6.2tCN¥2.3tCN¥185.3b31.8x33.5x2.7x
Sun, 17 Sep 2023CN¥6.3tCN¥2.3tCN¥186.5b32x33.8x2.7x
Tue, 15 Aug 2023CN¥6.4tCN¥2.3tCN¥193.7b32.2x32.9x2.8x
Thu, 13 Jul 2023CN¥6.5tCN¥2.3tCN¥192.1b33.1x33.8x2.9x
Sat, 10 Jun 2023CN¥6.7tCN¥2.3tCN¥191.5b34.6x35x3x
Mon, 08 May 2023CN¥7.0tCN¥2.3tCN¥192.4b36.7x36.5x3.1x
Wed, 05 Apr 2023CN¥7.0tCN¥2.2tCN¥234.4b36.7x30.1x3.1x
Fri, 03 Mar 2023CN¥7.2tCN¥2.2tCN¥229.5b38.9x31.4x3.3x
Sun, 29 Jan 2023CN¥7.4tCN¥2.2tCN¥233.4b37.8x31.9x3.4x
Tue, 27 Dec 2022CN¥6.8tCN¥2.2tCN¥232.2b35.4x29.1x3.1x
Thu, 24 Nov 2022CN¥6.9tCN¥2.2tCN¥231.8b37.4x29.7x3.1x
Price to Earnings Ratio

29.7x


Total Market Cap: CN¥6.9tTotal Earnings: CN¥231.8bTotal Revenue: CN¥2.2tTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Healthcare Sector Price to Earnings3Y Average 35.6x202320242025
Current Industry PE
  • Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 47.1x which is higher than its 3-year average PE of 35.6x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 14% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare sector?

CN Market-0.51%
Healthcare3.17%
Healthcare Services4.51%
Biotech4.08%
Pharma3.84%
Life Sciences1.47%
Medical Equipment1.12%
Healthtech-2.36%
Industry PE
  • Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 68.5x.
    • Analysts are expecting annual earnings growth of 42.8%, which is higher than its past year's earnings decline of 8.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 82% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Pharma industry is expected to see its earnings grow by 20% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
688506 Sichuan Biokin PharmaceuticalLtdCN¥371.626.2%
+CN¥9.0b		103.6%PS68.9x
600276 Jiangsu Hengrui PharmaceuticalsLtdCN¥62.902.1%
+CN¥8.7b		31.9%PE55.8x
300255 Hebei Changshan Biochemical PharmaceuticalCN¥58.9011.1%
+CN¥5.4b		202.1%PS58.3x
000963 Huadong MedicineCN¥43.157.1%
+CN¥5.0b		23.9%PE20.4x
688336 Sunshine Guojian Pharmaceutical (Shanghai)CN¥72.3710.9%
+CN¥4.4b		212.2%PE51.3x

Latest News

603014
CN¥41.58
Shandong Weigao Blood Purification Products
7D
-8.2%
1Y
n/a
688506
CN¥371.62
Sichuan Biokin PharmaceuticalLtd
7D
6.2%
1Y
103.6%
002317
CN¥26.00
Guangdong Zhongsheng Pharmaceutical
7D
24.5%
1Y
98.3%
688336
CN¥72.37
Sunshine Guojian Pharmaceutical (Shanghai)
7D
10.9%
1Y
212.2%
300255
CN¥58.90
Hebei Changshan Biochemical Pharmaceutical
7D
11.1%
1Y
202.1%
688271
CN¥136.88
Shanghai United Imaging Healthcare
7D
-0.6%
1Y
1.4%
603301
CN¥88.59
Zhende Medical
7D
-11.3%
1Y
282.5%
688351
CN¥23.79
Shanghai MicroPort EP MedTech
7D
-5.4%
1Y
16.8%
300049
CN¥71.53
Inner Mongolia Furui Medical Science
7D
-8.1%
1Y
91.1%
000963
CN¥43.15
Huadong Medicine
7D
7.1%
1Y
23.9%
688759
CN¥29.70
BeBetter Med
7D
-4.6%
1Y
n/a
002294
CN¥61.98
Shenzhen Salubris Pharmaceuticals
7D
6.1%
1Y
100.4%
600276
CN¥62.90
Jiangsu Hengrui PharmaceuticalsLtd
7D
2.1%
1Y
31.9%
002603
CN¥21.05
Shijiazhuang Yiling Pharmaceutical
7D
12.4%
1Y
20.6%
688765
CN¥86.02
Wuhan Healthgen Biotechnology
7D
-9.4%
1Y
n/a
688617
CN¥274.28
APT Medical
7D
-3.3%
1Y
18.0%